Typically, researchers construct cell-building scaffolds from synthetic materials or natural animal or human substances. Until now, however, no scaffolds grown in a Petri dish have been able to mimic the highly organized structure of the matrix made by living things. Researchers in Michigan have used a nano-grate to persuade fibroblasts to grow a scaffold with fibers just 80 nm, similar to to fibers in a natural matrix.
In the battle against infection, immune cells are the body's offense and defense. It has long...
Univ. of California, Berkeley researchers have shown that chronic stress generates long-term...
Stem cell research has been breaking ground in new application areas over the past few years, and it’s poised for even greater growth as more companies and organizations realize the potential. In the next decade, cell-based therapies will become increasingly common for cancer, immunological disorders, cardiac failure and other conditions.
The Salk Institute for Biological Studies will join Stanford Univ. in leading a new Center of Excellence in Stem Cell Genomics, created through a $40 million award by California's stem cell agency. The center will bring together experts and investigators from seven major California institutions to focus on bridging the fields of genomics with cutting-edge stem cell research and ultimately find new therapies.
A fundamental axiom of biology used to be that cell fate is a one-way street—once a cell commits to becoming muscle, skin or blood it always remains muscle, skin or blood cell. That belief was upended in the past decade when a Japanese scientist introduced four simple factors into skin cells and returned them to an embryonic-like state, capable of becoming of almost any cell type in the body.
Univ. of Oregon biologists say they have opened the window on the natural process of bone regeneration in zebra fish, and that the insights they gained could be used to advance therapies for bone fractures and disease. Their work shows that two molecular pathways work in concert to allow adult zebra fish to perfectly replace bones lost upon fin amputation.
Scientists in Japan have developed a new, surprisingly simple method for creating stem cell. In a pair of reports, the researchers show that ordinary somatic cells from newborn mice can be stripped of their differentiation memory, reverting to a state of pluripotency resembling embryonic stem cells and induced pluripotent stem cells. All that’s needed is a dose of sublethal stress.
A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. The discovery is a big step forward for stem cell research and for the high hopes for replacing damaged cells and thereby curing serious illnesses such as diabetes and Parkinson's disease.
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Now, investigators from the Massachusetts General Hospital and the Ragon Institute may have found HIV’s viral hiding place—in a small group of recently identified T-cells with stem cell-like properties.
A team of engineers at the Univ. of Wisconsin-Madison has created a process to improve the creation of synthetic neural stem cells for use in central nervous system research. The process, outlined in a paper published in Stem Cells, will improve the state of the art in the creation of synthetic neural stem cells for use in central nervous system research.
A new porous structure under development in German possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells in the laboratory. The specific reproduction of these hematopoietic cells outside the body might facilitate new therapies for leukemia in a few years.
Harvard Univ. stem cells scientists at Brigham and Women’s Hospital and Massachusetts Institute of Technology can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials across the U.S., more functional and efficient.
In the 2nd century BC, Indian surgeon Sushruta used autografted skin transplantation in nose reconstruction, also known as rhinoplasty. This was the first reasonable account of organ transplantation recorded. The first successful human corneal transplant was performed in 1905 in the Czech Republic, and the first steps to skin transplantation occurred during World War I. The first successful kidney transplant happened in 1962 in the U.S.
With the help of biomimetic matrices, a research team led by bioengineers at the Univ. of California, San Diego has discovered exactly how calcium phosphate can coax stem cells to become bone-building cells. The team has traced a surprising pathway from these biomaterials to bone formation. Their findings will help them refine the design of biomaterials that encourage stem cells to give rise to new bone.
The blood stem cells that live in bone marrow are at the top of a complex family tree. Such stem cells split and divide down various pathways that ultimately produce red cells, white cells and platelets. These “daughter” cells must be produced at a rate of about one million per second to constantly replenish the body’s blood supply. Researchers have long wondered what allows these stem cells to persist for decades, until now.
Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology. Now, a team of researchers has developed a novel platform to study kidney diseases, opening new avenues for the future application of regenerative medicine strategies to help restore kidney function.
Officials at the University of California, San Diego announced that philanthropist T. Denny Sanford has committed $100 million to the creation of the Sanford Stem Cell Clinical Center. The center is intended to accelerate development of drugs and therapies derived from human stem cell research through clinical trials and patient therapies.
Bioengineers at the Univ. of California, Berkeley have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage, capable of becoming any cell type in the body. The researchers grew fibroblasts on surfaces with parallel grooves measuring 10 µm wide and 3 µm high.
Stem cell therapy for heart disease is happening. Around the world, thousands of heart disease patients have been treated in clinical studies with some form of bone marrow cells or stem cells. But in these studies, the actual impact on heart function was modest or inconsistent. One reason is that most of the cells either don’t stay in the heart or die soon after being introduced into the body. Cardiology researchers have a solution.
Harvard Stem Cell Institute researchers have settled a century-old debate over whether occurrence of DNA methylation acts to silence gene expression, or if genes are turned off by other means before they are methylated. As explicated in Nature, methylation in fact enforces gene silencing.
Case Western Reserve Univ. researchers have published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers discovered that recombinant human prion protein stops the propagation of prions, the infectious pathogens that cause the diseases.
Univ. of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a “biobridge” that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
Induced pluripotent stem cells, or iPS cells, are a hot commodity right now in biology. The cells, which are created when non-stem cells are reprogrammed to resemble embryonic stem cells, have many potential uses in therapy and drug development. They're usually created by using a virus to add just four genes to the cell to be reprogrammed. However, a molecular understanding of the transformation process is largely lacking.
Scientists at Rice Univ. have trapped bismuth in a nanotube cage to tag stem cells for x-ray tracking. Bismuth is probably best known as the active element in a popular stomach-settling elixir and is also used in cosmetics and medical applications. Rice chemist Lon Wilson and his colleagues are inserting bismuth compounds into single-walled carbon nanotubes to make a more effective contrast agent for CT scanners.
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of Univ. of California, Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin, the fatty, insulating sheath essential to normal neural conduction.
At first glance, Botryllus schlosseri has very little in common with humans. And yet, Botryllus is humans' closest living invertebrate relative. Now, a group led by Stanford Univ. scientists has sequenced its genome, making it possible to find the genetic basis for some of the animal's amazing regenerative abilities and immunity features, which potentially could be applied to human medicine.
Stem cell therapy is in its infancy, but has the potential to change the way we treat cancer and other diseases by replacing damaged or diseased cells with healthy ones. Identifying the right cells to use is the challenge, and scientists in the U.K. have found a way to use gold nanoprobes with surface enhanced Raman spectroscopy to differentiate the nearly identical cells.
- Page 1